Phenazepam Stats & Data

• Phenazepam is a long‑acting benzodiazepine; TripSit’s benzo table lists an approximate 60 h half‑life, meaning effects and impairment can persist into the following days and accumulate with redosing. Plan doses with a multi‑day horizon and avoid daily use. • Relative potency is high: TripSit lists ~1 mg phenazepam ≈ 10 mg diazepam orally. Start at the low end (0.5–1 mg) and reassess after full onset; do not assume diazepam-like margins. • Because it is active at sub‑milligram to low‑milligram levels, eyeballing powder routinely leads to blackouts and multi‑day amnesia; use a 0.001 g scale and volumetric dosing. Numerous community harm‑reduction threads document severe consequences from mismeasurement. • Onset can be slow (up to 1–1.5 h or longer); redosing before the first dose peaks is a frequent cause of overdose and prolonged blackout. Wait several hours before considering any additional dose. • Avoid insufflation and injection: phenazepam is poorly water‑soluble and reports describe unreliable absorption and delayed effects by non‑oral routes, compounding overdose risk. • Polysubstance risk is high: combining benzodiazepines with alcohol, GHB/GBL, opioids, or tramadol markedly increases sedation and respiratory‑depression risk; if someone becomes unresponsive, place them in the recovery position and call emergency services. Do not attempt home reversal. • Counterfeit or mislabelled tablets are common in illicit markets (e.g., “Xanax/Valium” pressed with other benzos); use drug checking where available and be prepared for unexpected strength or different substances. • Benzodiazepine withdrawal can be severe and potentially life‑threatening; do not abruptly stop after extended or high‑dose use. Seek medical support for a gradual taper. (General benzo harm‑reduction guidance.) • Long half‑life plus amnesia increases risk of unsafe behaviors (driving, online purchases, interpersonal conflict) during multi‑day blackouts; secure access to the supply, log dose/time, and enlist a trusted sober person if needed. Community reports repeatedly describe multi‑day blackouts. • Cross‑tolerance with other benzodiazepines is expected; those with existing benzo tolerance may perceive little effect at low doses but still accrue impairment and dependence. • In some regions, benzodiazepines appear in opioid supplies (e.g., bromazolam/nordiazepam found in checked fentanyl samples), increasing overdose risk; test supplies and carry naloxone (note: naloxone does not reverse benzodiazepines).